Roundup Lawsuit FAQs

Short answer: Scientists disagree. In 2015 the World Health Organization’s cancer agency, IARC, classified glyphosate, Roundup’s active ingredient, as “probably carcinogenic to humans” (Group 2A), citing limited human evidence for non-Hodgkin lymphoma. The U.S. EPA concluded glyphosate is “not likely to be carcinogenic to humans” at relevant doses.IARC rates how strong the evidence of a [...]

Short answer: Federal MDL 2741 listed 916 pending actions on November 2, 2026. The proposed $7.25 billion class settlement was awaiting a final approval ruling in Missouri, after the Supreme Court’s June 2026 Durnell decision limited label-based failure-to-warn claims.DateEventJune 4, 2026Class opt-out deadlineJune 25, 2026Supreme Court decides DurnellSept. 14, 2026Final approval hearingNov. 2, 2026916 pending [...]

Short answer: On June 25, 2026, in Monsanto Co. v. Durnell, the Supreme Court held 7-2 that federal pesticide law (FIFRA) preempts a state-law claim that Monsanto should have added a cancer warning to Roundup’s EPA-approved label.What it meansFailure-to-warn claims based on the label are largely blocked.The decision does not foreclose every state-law claim against [...]

Short answer: The opt-out period closed June 4, 2026. Monsanto has said opt-outs remain revocable until final approval, so someone who opted out may still be able to rejoin before the court rules.People who did not opt out are generally bound by the settlement if it is approved.SourcesBayer statementbayer.comRoundup class FAQweedkillerclass.comChecked against primary sources on [...]

Short answer: Only after the settlement receives final approval and any appeals are resolved. Bayer has described funding the class through declining, capped annual payments for up to 21 years after approval, so payments to class members would be spread over time.No individual payment dates have been set. Ignore anyone charging a fee to speed [...]

Short answer: Generally, people exposed to Roundup before February 17, 2026 who have non-Hodgkin lymphoma now or are diagnosed within 16 years after final approval. People with a claim pending in federal MDL 2741 on February 17, 2026 are excluded unless they asked to be included and dismissed their MDL claim.Check the official settlement website [...]

Short answer: Yes, a proposed one. Monsanto’s $7.25 billion national class settlement for non-Hodgkin lymphoma claims received preliminary approval in a St. Louis, Missouri court, a fairness hearing was held September 14, 2026, and as of mid-November 2026 the court’s final approval decision was still pending.Final approval can be appealed. Payments would begin only after [...]